Thrombolytic therapy with tissue-type plasminogen activator: New modes and novel variant plasminogen activators
- 30 April 1991
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 2 (2) , 220-226
- https://doi.org/10.1016/0958-1669(91)90014-v
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Conjunctive Antithrombotic and Thrombolytic Therapy for Coronary-Artery OcclusionNew England Journal of Medicine, 1990
- Future directions in plasminogen activator therapyClinical Cardiology, 1990
- Effectiveness of multiple bolus administration of tissue-type plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- Intravenous bolus administration of recombinant tissue plasminogen activator to patients with acute myocardial infarctionCoronary Artery Disease, 1990
- After coronary thrombolysis and reperfusion, What next?Journal of the American College of Cardiology, 1989
- Thrombolytic Therapy in Acute Myocardial InfarctionAnnual Review of Medicine, 1989
- Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1987
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983